Viewing Study NCT06511869


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2026-01-02 @ 8:50 AM
Study NCT ID: NCT06511869
Status: COMPLETED
Last Update Posted: 2025-07-04
First Post: 2024-07-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AZD4205 in Peripheral T Cell Lymphoma Following First-Line Therapy (JACKPOT26)
Sponsor: Dizal Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module